Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline.

Overview of attention for article published in Hepatology, March 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 4 X users

guideline: 2 clinical guideline sources

Readers on

mendeley: 43 Mendeley

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 19,796 followers.

How does VCTE perform against MRE in MASH? MRE with a larger liver sampling area, more sens/specific at higher fibrosis stage, but higher $, lower availability than VCTE. VCTE may overestimate fibrosis stage compared to MRE. @YucaSpice @BachirTaouli…

How does VCTE perform against MRE in MASH detection? MRE with a larger liver sampling area, more sens/specific at higher fibrosis stage, but higher $, lower availability than VCTE. @YucaSpice @BachirTaouli https://t.co/SP74MdkDAt https://t.co/Ok8hP…

RT @ruben_hernaez: Thrilled to see this massive work @AASLDtweets @HEP_Journal @YucaSpice @RichSterlingMD guidelines: 1. Blood https://t.c…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.